Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Phase I/II Study of APS001F With Flucytosine and Maltose in Solid Tumors

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2016 by Anaeropharma Science, Inc.
Sponsor:
Information provided by (Responsible Party):
Anaeropharma Science, Inc.
ClinicalTrials.gov Identifier:
NCT01562626
First received: March 22, 2012
Last updated: February 22, 2016
Last verified: February 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2016
  Estimated Primary Completion Date: August 2016 (Final data collection date for primary outcome measure)